Roanoke Asset Management Corp Dexcom Inc Transaction History

Roanoke Asset Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $156,037 - $304,982	2,295 Added 300.0%	3,060 $228,000
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $1,948 - $2,442	-15 Reduced 1.92%	765 $411,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $21,012 - $24,849	-220 Reduced 22.0%	780 $322,000
Q2 2020 Aug 05, 2020	SELL	$62.68 - $105.34 $1,253 - $2,106	-20 Reduced 1.96%	1,000 $405,000
Q4 2019 Feb 05, 2020	BUY	$36.62 - $57.29 $37,352 - $58,435	1,020 New	1,020 $223,000
Q1 2019 Apr 29, 2019	SELL	$28.07 - $38.18 $48,841 - $66,433	-1,740 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$26.99 - $37.37 $1,619 - $2,242	-60 Reduced 3.33%	1,740 $208,000
Q3 2018 Oct 30, 2018	BUY	$23.35 - $36.72 $42,030 - $66,096	1,800 New	1,800 $257,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Roanoke Asset Management Corp with notifications on news.